Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
QL: Data curation, Investigation, Methodology, Software, Writing review & editing
No, patients should continue evidence-based addiction treatments including FDA-approved medications and behavioral interventions
Quick Answer: GLP-1 medications can increase bowel frequency and cause looser stools in some patients, though individual responses vary considerably
doi: 10.1038/s41598-017-09898-4 27 LuCXieTGuoXWuDLiSLiXet al
The most common user-reported experience: Temporary skin dryness in week 1 (resolves by week 2) Occasional injection site redness (standard for any subQ peptide) Some users report increased hair growth, including in unintended areas at higher doses At doses above 34 mg/day, some protocols note headaches, but this is well above standard dosing
/assets/images/provider/photos/2644266.jpg)
